Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Prognostic impact of tricuspid valve surgery for moderate regurgitation at the time of aortic valve replacement
Session:
Posters 4 - Écran 6 - Miscelânea
Speaker:
André de Lima Antunes
Congress:
CPC 2019
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Posters
FP Number:
---
Authors:
Antunes de Lima Antunes; Carlos Branco; Gonçalo Freitas Coutinho; David Prieto; Pedro Engrácia Antunes; Manuel Antunes
Abstract
<p><strong>Introduction:</strong> Significant functional tricuspid regurgitation (FTR) is associated with poor long-term survival due to a higher incidence of right-side heart failure. The management of FTR in patients with aortic valve disease seems to be as important as when it is associated with mitral valve disease. However, few studies have reported the impact of tricuspid valve disease at the time of aortic valve surgery.</p> <p><strong>Objective:</strong> We aimed to evaluate the impact in long-term survival of moderate FTR at the time of aortic valve surgery.</p> <p><strong>Methods:</strong> From January 2005 to November 2018, 258 consecutive patients underwent aortic valve replacement (AVR) and had preoperative moderate FTR. Of those patients, 63 had concomitant tricuspid valve surgery. Patients were divided in two groups: patients who had concomitant tricuspid valve surgery (AVR+TVS; n=63) and patients who had isolated AVR (n=195). Cox proportional hazards models were used to analyze risk factors for survival and Kaplan-Meier methods were used to plot survival curves.</p> <p><strong>Results:</strong> Mean age was (AVR+TVS vs. AVR) 70.2±10.0 vs. 72.6±9.3 years (p=0.096), 56.1% vs. 45.1% were male (p=0.384) and 42.9% vs 48.2% had severe aortic stenosis (p=0.472). Chronic pulmonary obstructive disease was present in 9.5% vs. 10.8% (p=0.779), preoperative atrial fibrillation in 59.7% vs. 34.4% (p=0.001), 61.9% vs. 49.2% were in NYHA class 3/4 (p=0.084) and 12.7% vs. 4.6% were redo surgery, respectively. Long term survival at 10 years was similar between the two groups (61.6±8.1 vs. 48.7±6.4, p=0.512) as well as the incidence of major adverse cardiac and cerebrovascular events in long term follow up (42.9±10.1 vs. 51.0±5.5, p=0.349)</p> <p><strong>Conclusion:</strong> Adding tricuspid valve annulloplasty for moderate regurgitation at the time of aortic valve replacement did not show a significant impact in long term outcomes in this patients.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site
